Company news
Design Therapeutics, Inc. news in 2021
Design Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
November 8, 2021
Design Therapeutics Announces Positive Preclinical Data Highlighting Disease-Modifying Potential of its Novel DM1 GeneTACs as a Treatment for Myotonic Dystrophy Type-1
September 7, 2021
Design Therapeutics Reports GeneTAC™ Portfolio Progress and Second Quarter 2021 Results
August 8, 2021
Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
June 6, 2021
Design Therapeutics Expands Board of Directors with Key Appointments
June 6, 2021
Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
May 9, 2021
Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 29, 2021
Design Therapeutics Announces Pricing of Initial Public Offering
March 24, 2021